STAAR Surgical (STAA) Tops Q3 EPS by 10c, Revenues Beat; 'Raises Outlook for Full Year 2018'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Wall St set for higher open after Micron revives AI optimism, upbeat economic data
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- IBM surges on unveiling sub-1nm chip technology breakthrough
- 'Long-term deals significant positive for stock:' Analysts react to Micron results
STAAR Surgical ICL Sales Up 46%; Company Raises Outlook for Full Year 2018
October 31, 2018 4:01 PM EDTMONROVIA, Calif.--(BUSINESS WIRE)-- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the third quarter ended September 28, 2018.
Third Quarter 2018 Overview
Net Sales of $31.8 Million Up 35% from the Prior Year Quarter ICL Sales Up 46% and Units Up 56% from the Prior Year Quarter Gross Margin at 75.1% of Sales from 71.8% of Sales in the Prior Year Quarter... More